市場調查報告書

HbA1c檢驗的全球市場:至2025年的預測

Global HbA1c Testing Market Research Report - Forecast till 2025

出版商 Market Research Future 商品編碼 922984
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
HbA1c檢驗的全球市場:至2025年的預測 Global HbA1c Testing Market Research Report - Forecast till 2025
出版日期: 2019年12月01日內容資訊: 英文 134 Pages
簡介

全球HbA1c檢驗市場至2025年預計將以12.24%的年複合成長率發展,成長到19億9,244萬美元的規模。糖尿病是世界上患者數多的疾病之一,估計至2030年糖尿病成為全球死因的第7名。HbA1c檢驗,為了確知患者過去2∼3個月的平均血糖值而進行。糖尿病患者及診斷的數量增加,成為HbA1c檢驗市場成長的促進因素。

本報告提供全球HbA1c檢驗市場調查,市場概要,各產品、技術、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 摘要整理

  • 市場概要
  • 市場魅力分析
  • 全球HbA1檢驗市場:各產品
  • 全球HbA1檢驗市場:各技術
  • 全球HbA1檢驗市場:各終端用戶

第2章 市場介紹

  • 定義
  • 調查範圍
  • 調查目的
  • 市場結構
  • 假設與限制

第3章 調查方法

  • 資料探勘
  • 二次研究
  • 一次研究
  • 預測技術
  • 估計市場規模的調查方法
  • 資料的三角形分割
  • 檢驗

第4章 市場動態

  • 概要
  • 成長要素
    • 糖尿病患者的增加
    • 主要企業的舉措增加
    • 糖尿病研究機關的增加
    • 老年人口的增加與不健康的伙食的影響
  • 阻礙因素
    • HbA1c檢驗的適應症的限制
    • 開發中國家的嚴格的償付政策
  • 市場機會
    • 核准數量的增加與產品的銷售
    • 對HbA1c檢驗設備的各種技術編入

第5章 市場影響要素分析

  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 價值鏈分析
    • 研究開發與設計
    • 製造
    • 流通
    • 行銷銷售
    • 銷售後監視

第6章 全球HbA1c檢驗市場:各產品

  • 概要
  • 試劑、套件
  • 設備
    • 桌上型
    • 手持型

第7章 全球HbA1c檢驗市場:各技術

  • 概要
  • 離子交換HPLC
  • 酵素化驗
  • 濁度檢測免疫測量(TINIA)
  • 其他

第8章 全球HbA1c檢驗市場:各終端用戶

  • 概要
  • 醫院、診所
  • 診斷檢驗室
  • 其他

第9章 全球HbA1c檢驗市場:各地區

  • 概要
  • 南北美洲
    • 概要
    • 北美
    • 中南美
  • 歐洲
    • 概要
    • 西歐
    • 東歐
  • 亞太地區
    • 概要
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他地區
  • 中東、非洲
    • 概要
    • 中東
    • 非洲

第10章 競爭情形

  • 概要
  • 企業佔有率分析

第11章 企業簡介

  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES, INC.
  • DANAHER CORPORATION
  • F. HOFFMANN-LA ROCHE LTD
  • SIEMENS HEALTHINEERS
  • EKF DIAGNOSTICS
  • ARKRAY, INC.
  • TRINITY BIOTECH PLC.
  • PTS DIAGNOSTICS
  • DIASYS DIAGNOSTIC SYSTEMS GMBH

第12章 附錄

  • 參考文獻
  • 相關報告
目錄

Global HbA1c Testing Market: Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market analysis:

In general, diabetes has become one of the most prevalent epidemics across the world, and among the three types of diabetes, type 2 diabetes is the most common. Agreeing to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes is anticipated to be the seventh prominent cause of death by 2030. Moreover, according to data published by the International Diabetes Federation in 2017, the prevalence of diabetes in Brazil was 8.7% among adults and reported 12,465,800 cases of diabetes in 2017. HbA1c Testing Market is anticipated to enroll a CAGR of 12.24% to reach USD 1,992.44 Million by 2025. Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months. These ever-increasing occurrences push for various testing methods such as HbA1c testing in patients for diagnosis. Therefore, this factor is supporting the market growth of the global HbA1c testing market.

Market segmentation:

The global HbA1c testing market has been segmented by product, technology, and end user respectively. The market, based on product, has been split into reagents and kits and instruments. The market, based on instruments, has been further segmented into a bench-top device and handheld device. Based on technology, the HbA1c testing market has been separated into ion-exchange HPLC, enzymatic assay, TINIA, and others. The global HbA1c testing market, based on end user, has been divided into hospitals and clinics, diagnostic laboratories, and others.

Regional analysis:

Geographically the Global HbA1c testing market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The European market for HbA1c testing is expected to be the second largest during the review period. Their growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as relationships and agreements by the prominent players is expected to boost the growth of the regional market. Asia-Pacific is estimated to be the fastest-growing market owing to the developing healthcare infrastructure and ever-increasing per capita disposable incomes. The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare. The growing awareness regarding healthcare and the availability of new advanced treatment options are factors expected to drive the growth of the market in the region. The Global HbA1c Testing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is likely to dominate the global HbA1c testing market. This can be attributed to growing activities such as research, recognition campaigns, and joint ventures by public and private organizations in the US and Canada.

Major players:

The proposed spectators in the Global HbA1c testing market are Detonator manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global HbA1c testing market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global HbA1c testing market are companies like Agappe Diagnostics Ltd (India), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), PTS Diagnostics (US), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), Tosoh India Pvt. Ltd. (India) and DiaSys Diagnostic Systems GmbH (Germany).

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 MARKET SYNOPSIS
  • 1.2 MARKET ATTRACTIVENESS ANALYSIS
  • 1.3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT
  • 1.4 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY
  • 1.5 GLOBAL HBA1C TESTING MARKET, BY END USER

2 Market Introduction

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 Research Methodology

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF DIABETES
    • 4.2.2 INCREASING INITIATIVES BY KEY PLAYERS
    • 4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES
    • 4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET
  • 4.3 RESTRAINTS
    • 4.3.1 LIMITED INDICATIONS OF HBA1C TESTS
    • 4.3.2 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES
    • 4.4.2 INCORPORATION OF VARIOUS TECHNOLOGIES IN HBA1C TESTING INSTRUMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 VALUE CHAIN ANALYSIS
    • 5.2.1 R&D AND DESIGNING
    • 5.2.2 MANUFACTURING
    • 5.2.3 DISTRIBUTION
    • 5.2.4 MARKETING & SALES
    • 5.2.5 POST-SALES MONITORING

6 GLOBAL HBA1C TESTING MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 REAGENTS & KITS
  • 6.3 INSTRUMENTS
    • 6.3.1 BENCH-TOP DEVICE
    • 6.3.2 HANDHELD DEVICE

7 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY

  • 7.1 OVERVIEW
  • 7.2 ION-EXCHANGE HPLC
  • 7.3 ENZYMATIC ASSAY
  • 7.4 TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA)
  • 7.5 OTHERS

8 GLOBAL HBA1C TESTING MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS AND CLINICS
  • 8.3 DIAGNOSTIC LABORATORIES
  • 8.4 OTHERS

9 GLOBAL HBA1C TESTING MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 AMERICAS
    • 9.2.1 OVERVIEW
    • 9.2.2 NORTH AMERICA
    • 9.2.3 LATIN AMERICA
  • 9.3 EUROPE
    • 9.3.1 OVERVIEW
    • 9.3.2 WESTERN EUROPE
    • 9.3.3 EASTERN EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 OVERVIEW
    • 9.4.2 CHINA
    • 9.4.3 INDIA
    • 9.4.4 JAPAN
    • 9.4.5 SOUTH KOREA
    • 9.4.6 AUSTRALIA
    • 9.4.7 REST OF ASIA-PACIFIC
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 OVERVIEW
    • 9.5.2 MIDDLE EAST
    • 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPANY SHARE ANALYSIS, 2018 (%)

11 COMPANY PROFILES

  • 11.1 ABBOTT LABORATORIES
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 BIO-RAD LABORATORIES, INC.
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 DANAHER CORPORATION
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 F. HOFFMANN-LA ROCHE LTD
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 SIEMENS HEALTHINEERS
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 EKF DIAGNOSTICS
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS/SERVICES OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES

  • 11.7 ARKRAY, INC.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS/SERVICES OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 TRINITY BIOTECH PLC.
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS/SERVICES OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 PTS DIAGNOSTICS
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS/SERVICES OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 DIASYS DIAGNOSTIC SYSTEMS GMBH
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS/SERVICES OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

List of Tables

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 4 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 5 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 6 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL HBA1C TESTING MARKET FOR BENCH-TOP DEVICE, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 8 GLOBAL HBA1C TESTING MARKET FOR HANDHELD DEVICE, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 9 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 10 GLOBAL HBA1C TESTING MARKET FOR ION-EXCHANGE HPLC, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 11 GLOBAL HBA1C TESTING MARKET FOR ENZYMATIC ASSAY, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 12 GLOBAL HBA1C TESTING MARKET FOR TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA), BY REGION, 2016-2025 (USD MILLION)
  • TABLE 13 GLOBAL HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 14 GLOBAL HBA1C TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 15 GLOBAL HBA1C TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 16 GLOBAL HBA1C TESTING MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 17 AMERICAS: HBA1C TESTING MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 18 AMERICAS: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 19 AMERICAS: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 20 AMERICAS: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 21 AMERICAS: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 22 NORTH AMERICA: HBA1C TESTING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 23 NORTH AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 24 NORTH AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 25 NORTH AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 26 NORTH AMERICA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 27 US: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 28 US: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 29 US: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 30 US: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 31 CANADA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 32 CANADA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 33 CANADA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 34 CANADA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 35 LATIN AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 36 LATIN AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 37 LATIN AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 38 LATIN AMERICA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 39 EUROPE: HBA1C TESTING MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 40 EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 41 EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 42 EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 43 EUROPE: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: HBA1C TESTING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 49 UK: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 50 UK: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 51 UK: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 52 UK: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 53 GERMANY: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 54 GERMANY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 55 GERMANY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 56 GERMANY: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 57 FRANCE: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 58 FRANCE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 59 FRANCE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 60 FRANCE: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 61 ITALY: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 62 ITALY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 63 ITALY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 64 ITALY: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 65 SPAIN: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 66 SPAIN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 67 SPAIN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 68 SPAIN: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 72 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 73 EASTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 76 EASTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: HBA1C TESTING MARKET, BY COUNTRY,2016-2025 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 82 CHINA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 83 CHINA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 84 CHINA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 85 CHINA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 86 INDIA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 87 INDIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 88 INDIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 89 INDIA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 90 JAPAN: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 91 JAPAN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 92 JAPAN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 93 JAPAN: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 94 SOUTH KOREA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 95 SOUTH KOREA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 96 SOUTH KOREA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 97 SOUTH KOREA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 98 AUSTRALIA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 99 AUSTRALIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 100 AUSTRALIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 101 AUSTRALIA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 102 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 103 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 104 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 105 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY REGION,2016-2025 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 111 MIDDLE EAST: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 112 MIDDLE EAST: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 113 MIDDLE EAST: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 114 MIDDLE EAST: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 115 AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 116 AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 117 AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
  • TABLE 118 AFRICA: HBA1C TESTING MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 119 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 120 ABBOTT LABORATORIES: KEY DEVELOPMENTS
  • TABLE 121 BIO-RAD LABORATORIES INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 122 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS
  • TABLE 123 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 124 DANAHER CORPORATION: KEY DEVELOPMENTS
  • TABLE 125 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED
  • TABLE 126 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS
  • TABLE 127 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED
  • TABLE 128 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS
  • TABLE 129 EKF DIAGNOSTICS PRODUCTS/SERVICES OFFERED
  • TABLE 130 EKF DIAGNOSTICS KEY DEVELOPMENTS
  • TABLE 131 ARKRAY, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 132 ARKRAY, INC.: KEY DEVELOPMENTS
  • TABLE 133 TRINITY BIOTECH PLC.: PRODUCTS/SERVICES OFFERED
  • TABLE 134 PTS DIAGNOSTICS: PRODUCTS/SERVICES OFFERED
  • TABLE 135 DIASYS DIAGNOSTIC SYSTEMS GMBH: PRODUCTS/SERVICES OFFERED

List of Figures

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2018)
  • FIGURE 3 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY PRODUCT
  • FIGURE 4 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY TECHNOLOGY
  • FIGURE 5 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY END USER
  • FIGURE 6 GLOBAL HBA1C TESTING MARKET: STRUCTURE
  • FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET
  • FIGURE 9 DRIVERS IMPACT ANALYSIS
  • FIGURE 10 RESTRAINT IMPACT ANALYSIS
  • FIGURE 11 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HBA1C TESTING MARKET
  • FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET
  • FIGURE 13 GLOBAL HBA1C TESTING MARKET SHARE, BY PRODUCT, 2018 (%)
  • FIGURE 14 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2018 & 2025 (USD MILLION)
  • FIGURE 15 GLOBAL HBA1C TESTING MARKET SHARE, BY TECHNOLOGY, 2018 (%)
  • FIGURE 16 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2018 & 2025 (USD MILLION)
  • FIGURE 17 GLOBAL HBA1C TESTING MARKET SHARE, BY END USER, 2018 (%)
  • FIGURE 18 GLOBAL HBA1C TESTING MARKET, BY END USER, 2018 & 2025 (USD MILLION)
  • FIGURE 19 GLOBAL HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 20 GLOBAL HBA1C TESTING MARKET, BY REGION, 2018 AND 2025 (USD MILLION)
  • FIGURE 21 AMERICAS: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 22 NORTH AMERICA: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%)
  • FIGURE 23 EUROPE: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 24 WESTERN EUROPE: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%)
  • FIGURE 25 ASIA-PACIFIC: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%)
  • FIGURE 26 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 27 GLOBAL HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2018 (%)
  • FIGURE 28 INDIA HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2018 (%)
  • FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS
  • FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 BIO-RAD LABORATORIES INC: SWOT ANALYSIS
  • FIGURE 33 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 DANAHER CORPORATION: SWOT ANALYSIS
  • FIGURE 35 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
  • FIGURE 37 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS
  • FIGURE 39 EKF DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 EKF DIAGNOSTICS: SWOT ANALYSIS
  • FIGURE 41 ARKRAY, INC.: SWOT ANALYSIS
  • FIGURE 42 TRINITY BIOTECH PLC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 TRINITY BIOTECH PLC.: SWOT ANALYSIS
  • FIGURE 44 PTS DIAGNOSTICS: SWOT ANALYSIS
  • FIGURE 45 DIASYS DIAGNOSTIC SYSTEMS GMBH: SWOT ANALYSIS